orphan drugs

Tetra Discovery Partners Initiates Ph II Trial of Fragile X Syndrome Drug
CP Wire
Tue, 07/10/18 - 11:10 am
Tetra Discovery Partners
Fragile X syndrome
BPN14770
clinical trials
orphan drugs
Eagle Receives Orphan Drug Designation for Bendeka
CP Wire
Mon, 07/9/18 - 10:52 am
Eagle Pharmaceuticals
orphan drugs
Bendeka
Treanda
Are Orphan Drugs Getting Too Much Attention By Payers And Policymakers?
Forbes
Mon, 06/25/18 - 08:58 pm
orphan drugs
payers
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
Wed, 05/30/18 - 09:13 pm
orphan drugs
Celgene
Revlimid
Roche
Rituxan
Teva Pharmaceutical
Copaxone
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
Half of orphan drug sales to come from cancer, Evaluate finds
Biopharma Dive
Wed, 05/30/18 - 08:20 pm
oncology
orphan drugs
Orphan drugs to grow twice as fast as rest of the industry: report
Medical Marketing and Media
Sat, 05/26/18 - 09:25 am
orphan drugs
Market Exclusivity is not What Attracts Orphan Drug Investment, Research Finds
RAPS.org
Mon, 05/7/18 - 10:13 pm
market exclusivity
orphan drugs
Eloxx Receives Another Orphan-Drug Designation for ELX-02
CP Wire
Fri, 04/27/18 - 08:12 pm
Eloxx Pharmaceuticals
ELX-02
orphan drugs
FDA
cystinosis
EU Advisory Group Backs Orphan Drug Designation for Alnylam's ALN-TTRsc02 for ATTR Amyloidosis
CP Wire
Mon, 04/23/18 - 11:01 am
Alnylam
EMA
orphan drugs
ALN-TTRsc02
ATTR amyloidosis
No slowing down: Orphan drug designations skyrocket in 2017
Medical Marketing and Media
Wed, 03/21/18 - 09:29 am
orphan drugs
FDA
Analyzing the orphan drugs market ($127bn)
GoinPharma
Fri, 03/2/18 - 09:48 am
orphan drugs
Shire
Baxalta
Sanofi
Bioverativ
M&A
FDA to Launch New Pilot Program for Orphan Designation Requests
RAPS.org
Mon, 02/26/18 - 11:14 pm
FDA
orphan drugs
Despite increased spending, orphan drugs still small piece of US medicines market
Biopharma Dive
Thu, 10/19/17 - 09:19 am
orphan drugs
drug pricing
FDA is Advancing the Goals of the Orphan Drug Act
FDA Voice
Tue, 09/12/17 - 09:55 pm
FDA
orphan drugs
Orphan Drug Act
FDA Determines that Deuterated Compounds are NCEs and Different Orphan Drugs Versus Non-deuterated Versions
FDA Law Blog
Mon, 07/17/17 - 10:00 am
FDA
deuterated drugs
NCEs
Austedo
Teva Pharmaceutical
orphan drugs
FDA Plots Elimination of the Orphan Drug Designation Request Backlog
RAPS.org
Thu, 06/29/17 - 02:23 pm
FDA
orphan drugs
Orphan drug market set to climb above $200B: Report
Fierce Pharma
Thu, 06/22/17 - 01:30 pm
orphan drugs
FDA User Fee Package Includes “Technical Corrections” to Address Orphan Drug Clinical Superiority
FDA Law Blog
Tue, 05/9/17 - 10:23 am
FDA
orphan drugs
Celgene, BMS, Novartis expected to top 2022 orphan drug market worth $209B: report
Fierce Pharma
Sat, 03/4/17 - 01:59 pm
Celgene
Novartis
Bristol-Myers Squibb
orphan drugs
Revlimid
Grunenthal snags a PhIII-ready orphan drug in Thar Pharma buyout
Endpoints
Thu, 11/17/16 - 09:29 am
Grunenthal
Thar Pharmaceuticals
T121
orphan drugs

Pages